Asset Publisher Asset Publisher

Return to Full Page

khashayar karimian

 

                                    
 
 
Khashayar Karimian
Professor 
Ph.D. Bioorganic Chemistry, Louisiana State University, 1976
E-mail: kkarimian@arsato.com
 
 
                                                                                                                                   

                                          

ACADEMIC POSITIONS:

2013-               Invited Member, Chemistry Branch of the Iranian Academy of Science

2010-               Adjunct Professor, Department of Chemical Engineering, College of Engineering, University of Tehran

2002-               Adjunct Professor of Biochemistry, Institute of Biochemistry and Biophysics, University of Tehran

1996-1999       Member, Grant Selection Committee (Chemistry and Biochemistry), National Science and Engineering Research Council (NSRC) of Canada.

1996-1999       Member, Grant Selection Committee for Major Instruments (Chemistry and Biochemistry), National Science and Engineering Research Council (NSERC) of    Canada.

1985-1989       Visiting Professor and Lecturer, Department of Chemistry, University of Toronto

1979-1985       Assistant Professor of Biochemistry, Institute of Biochemistry and Biophysics, University of Tehran

 

INDUSTRIAL POSITIONS:

2015-                  Chairman, Ajand Pharmaceutical Holding Inc.

2014-                  President, Andisheh Pharmaceutical Sciences Research Center Inc.

2011-                  Vice President, Pharmaceutical Active ingredients, Chemicals and Packaging Material Syndicate (Iran)

2002-2012          Chairman and President, Arasto Pharmaceutical Chemicals Inc.

2002-                  Chairman, Avicenna Pharmaceuticals Inc.

1996-2003          Chief Scientific Officer, Medicinal Chemistry, Apotex Research Inc.

1996-1999          Head, Medicinal Chemistry, Apotex Inc.

1995-1996          General Manager, Fine Chemicals Division, Apotex Research Inc.

1994-1995          Director, Fine Chemicals Division, Apotex Research Inc.

1993-1994          Special Advisor, Apotex Inc.

1990-1992          Vice President, Scientific Affairs, ACIC (Canada) Inc.

1988-1990          Vice President, Research and Development, ACIC (Canada) Inc.

1986-1988          Director of Research and Development, ACIC (Canada) Inc.

1980-1984          Member of the Board of Directors, Iran Active Charcoal Company.

1979-1984          Consultant to the Board of Directors, Fine Chemicals Industries (TEMAD), Iranian Ministry of Health.

1979-1984          Consultant to the Board of Directors, Center for Pharmaceutical Research (DP).Iranian Ministry of Health.

 

GRANTS:

2017-2019       Presidential National Grants for Science-Based Companies (Arasto Pharmaceutical Chemicals Inc.) 24 Billion Rials (US $ 686,000),

2017-2019       Presidential National Grants for Science-Based Companies (Avicenna Laboratories Inc.) 14 Billion Rials (US $ 400,000),

2012-2015       Presidential National Major Research Grant 18 Billion Rials (US $ 1.6 Million),

"Industrial Production of 9 Anti-Cancer Active Pharmaceutical Ingredients and the Processes Thereof"

1998-2001       Ontario Research and Development Challenge Fund Grant No. 113-98UI CAN $ 750,000.  Collaborative research with Dept. of Biophysics, University of Toronto, "Rational Design of Human Rhinovirous 3C Protease Inhibitors"

1998-2001       National Science and Engineering Research Council Grant No. CRD 661-104-97 CAN $ 190,000, Collaborative research with Dept. of Chemistry, University of Montreal, "Rational Design of Trans-glutaminase Inhibitors"

1995-1998       National Research Council, Industrial Research Assistance Program Grant No. 25323U CAN $ 1,050,000.  Collaborative research with School of Medicine, McMaster University, "Rational Design of 1,2,4-thiadiazole: A Novel Class of Potential Therapeutics for the Treatment of Ulcer".

1989-1992       National Research Council, Industrial Research Assistance Program Grant No. 90765 CAN $ 80,000.  Collaborative research with Cross Cancer Institute, University of Alberta, "Rational Design of 3'-Cyclocitidines: A Novel Class of Potential Anti-neoplastics".

1982-1985       Iranian Organization for Scientific and Industrial Research Grant CAN $ 30,000. "Economical Synthesis of Ara-C and Related Novel Anti-neoplastics".

1979-1982       University of Tehran Operating Grant No. 36-426 CAN $ 200,000. Institute of Biochemistry and Biophysics, University of Tehran, "Mechanism of Exchange of   C-2 Proton in Thiazolium Salts".

1979-1980       Ministry of Science and Higher Education Grant No. 600-5-36-3 CAN $ 100,000. Institute of Biochemistry and Biophysics, University of Tehran, "Mechanism of Exchange of C-2 Proton in Thiazolium Salts".